Cargando…
CAR-T State of the Art and Future Challenges, A Regulatory Perspective
This review is an outlook on CAR-T development up to the beginning of 2023, with a special focus on the European landscape and its regulatory field, highlighting the main features and limitations affecting this innovative therapy in cancer treatment. We analysed the current state of the art in the E...
Autores principales: | Giorgioni, Lorenzo, Ambrosone, Alessandra, Cometa, Maria Francesca, Salvati, Anna Laura, Magrelli, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380644/ https://www.ncbi.nlm.nih.gov/pubmed/37511562 http://dx.doi.org/10.3390/ijms241411803 |
Ejemplares similares
-
Haemophilia, state of the art and new therapeutic opportunities, a regulatory perspective
por: Tomeo, Francesca, et al.
Publicado: (2021) -
Neuroenhancement: State of the Art and Future Perspectives
por: Marazziti, Donatella, et al.
Publicado: (2021) -
The Use of Calcium Phosphates in Cosmetics, State of the Art and Future Perspectives
por: Carella, Francesca, et al.
Publicado: (2021) -
CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
por: Rodríguez-Lobato, Luis Gerardo, et al.
Publicado: (2020) -
CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
por: Mardiana, Sherly, et al.
Publicado: (2020)